Abridge has secured $300 million in Series E funding led by Andreessen Horowitz (a16z), with participation from Khosla Ventures, to scale its AI-driven clinical documentation and revenue cycle management (RCM) platform. Already deployed in over 150 enterprise health systems across 55 specialties and 28 languages, Abridge is transforming point-of-care conversations into real-time, compliant clinical notes and billing codes. Its Contextual Reasoning Engine supports the latest CMS-HCC guidelines, helping clinicians capture accurate diagnoses and documentation without added cognitive burden. Clinician burnout has dropped by 60–70% among users, and over 90% continue using Abridge meaningfully. With this funding, Abridge aims to further automate downstream RCM tasks, reduce denials, accelerate reimbursement cycles, and enhance coordination across care teams.
Keep Reading
Add A Comment